Kronox Lab Sciences Limited has informed the Exchange regarding Board meeting held on August 11, 2025 to consider and approve Un-audited financial Results for the quarter ended June 30, 2025
KRONOX · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 5.5 pts less than Nifty Microcap 250 and 5.4 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Kronox Lab Sciences' board, at its meeting on August 11, 2025, approved the unaudited standalone financial results for the quarter ended June 30, 2025. Revenue from operations stood at Rs 2,428.65 lakhs, down about 3.6% from Rs 2,519.26 lakhs in Q1 FY25. Total income fell to Rs 2,515.97 lakhs from Rs 2,562.48 lakhs, but total expenses also dipped, helping profit before tax edge up to Rs 844.05 lakhs (vs Rs 830.79 lakhs). Profit after tax rose to Rs 627.87 lakhs (up ~2.1% YoY) and EPS came in at Rs 1.70 versus Rs 1.67 a year ago. The statutory auditor, Mahesh Udhwani & Associates, issued an unmodified limited review report with no qualifications or emphasis-of-matter paragraphs.
Mildly mixed outcome: topline contracted YoY while margins and bottom line held up modestly, suggesting cost discipline. With no auditor flags, near-term stock reaction is likely to be muted, and investors will watch for management commentary on demand recovery in the coming quarters.